Unknown

Dataset Information

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.


ABSTRACT:

Background

Mitoxantrone is used for aggressive multiple sclerosis (MS), but concerns about safety, including cardiotoxicity and other laboratory measures, prevail.

Objective

To evaluate the incidence and potential predictors of adverse events associated with mitoxantrone at the MS Clinic, University of British Columbia, Canada.

Methods

Retrospective review of patients treated with mitoxantrone by standard protocol; maximum cumulative dose = 120 mg/m(2). Left ventricular ejection fraction (LVEF) was measured with regular multiple-gated acquisition (MUGA) scans; blood cell counts and biochemical liver tests were performed before infusions. Generalized estimating equations were used to examine potential predictors of adverse events (graded according to the Common Toxicit

SUBMITTER: Kingwell E 

PROVIDER: S-EPMC2882218 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature